Cronos Group Inc.
CRON.TO
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.21B
Close$
Share Statistics
| Market cap | $1.21 Billion |
|---|---|
| Enterprise Value | $742.88 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 6.53% |
|---|---|
| Return on Assets | 5.91% |
| Return on Invested Capital | 4.35% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.91 |
| Enterprise Value to EBIT | 15.19 |
| Enterprise Value to Net Income | 10 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cronos Group Inc
610 employees
CEO: Michael Ryan Gorenstein Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under...